Previous close | 66.45 |
Open | 66.10 |
Bid | 65.30 x 0 |
Ask | 65.40 x 0 |
Day's range | 64.80 - 66.45 |
52-week range | 64.80 - 90.00 |
Volume | |
Avg. volume | 1,244,675 |
Market cap | 25.026B |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | 17.47 |
EPS (TTM) | 3.75 |
Earnings date | 28 Aug 2024 |
Forward dividend & yield | 2.40 (3.66%) |
Ex-dividend date | 26 Feb 2024 |
1y target est | 77.17 |
Investing.com -- Stockholm-listed shares in Elekta (ST:EKTAb) dropped to bottom of the pan-European Stoxx 600 on Wednesday after the Swedish radiation therapy group reported a fall in fourth-quarter profit that was larger than anticipated.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions.